Breaking News Instant updates and real-time market news.

NBIX

Neurocrine

$120.45

-0.79 (-0.65%)

04:55
08/29/18
08/29
04:55
08/29/18
04:55

Neurocrine management to meet with Needham

Meeting to be held in Chicago on August 29 hosted by Needham.

  • 29

    Aug

  • 30

    Aug

  • 31

    Aug

  • 12

    Sep

NBIX Neurocrine
$120.45

-0.79 (-0.65%)

08/01/18
JEFF
08/01/18
NO CHANGE
Target $131
JEFF
Buy
Neurocrine price target raised to $131 from $124 at Jefferies
Jefferies analyst Biren Amin raised his price target for Neurocrine Biosciences to $131 saying Ingrezza posted a "strong beat" in Q2. Further, the analyst sees "several catalysts" before year-end. A "strong" Orilissa launch could lift shares and management reiterated that the Phase IIb T-Force GOLD study in Tourette's is on track for topline data by the end of 2018, Amin tells investors in a research note. He keeps a Buy rating on Neurocrine.
08/07/18
STFL
08/07/18
INITIATION
Target $137
STFL
Buy
Neurocrine initiated with a Buy, added to Select List at Stifel
Stifel analyst Paul Matteis initiated coverage of Neurocrine Biosciences with a Buy rating and $137 price target and added the stock to the firm's Select List. He sees Ingrezza in Tardive Dyskineisa having "blockbuster potential" and believes the drug has "a reasonable shot at succeeding" and expanding its market in Tourette's Syndrome. He also estimates cash flows from Elagolix could be worth close to $2B, Matteis tells investors.
08/22/18
JEFF
08/22/18
NO CHANGE
Target $131
JEFF
Buy
Neurocrine could rally $15 on positive Tourette's data, says Jefferies
Jefferies analyst Biren Amin believes shares of Neurocrine Biosciences could rally $10-$15 on the year-end readout for the Phase IIb T-Force Gold study in pediatric Tourette's syndrome. The analyst's work indicates that a Yale Global Tic Severity Scale score reduction of 25%-30%, or seven-to-ten patients, over placebo would likely be considered clinically meaningful by doctors. Positive data within or above this range could see shares trade up by up to $15, while a near miss could send the stock down by $8-$10, Amin tells investors in a research note. He keeps a Buy rating on Neurocrine with a $131 price target.
08/22/18
CANT
08/22/18
INITIATION
Target $150
CANT
Overweight
Neurocrine initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan initiated Neurocrine with an Overweight and $150 price target.

TODAY'S FREE FLY STORIES

GBL

GAMCO Investors

$26.00

0.44 (1.72%)

, GCP

GCP Applied Technologies

$26.25

0.25 (0.96%)

16:14
09/20/18
09/20
16:14
09/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, GCP Applied Technologies »

Gabelli reports 5% stake…

GBL

GAMCO Investors

$26.00

0.44 (1.72%)

GCP

GCP Applied Technologies

$26.25

0.25 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSLT

Castlight Health

$2.90

0.1 (3.57%)

16:13
09/20/18
09/20
16:13
09/20/18
16:13
Hot Stocks
Breaking Hot Stocks news story on Castlight Health »

Neil Gagnon reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.87

0.575 (1.73%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
Breaking Hot Stocks news story on United Natural Foods »

United Natural Foods down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

UNFI

United Natural Foods

$33.79

0.5 (1.50%)

16:12
09/20/18
09/20
16:12
09/20/18
16:12
Hot Stocks
United Natural Foods says results reflect higher than anticipated freight costs »

"We continued to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Hot Stocks
Breaking Hot Stocks news story on Steelcase »

Steelcase up 9.9% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FATE

Fate Therapeutics

$13.99

0.64 (4.79%)

16:11
09/20/18
09/20
16:11
09/20/18
16:11
Syndicate
Fate Therapeutics files to sell common stock, no amount given »

Jefferies, Piper Jaffray,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.10

0.8 (5.23%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Earnings
Breaking Earnings news story on Steelcase »

Steelcase sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

T

AT&T

$33.38

0.02 (0.06%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
AT&T recommends that shareholders reject mini-tender from Ponos Industries »

AT&T has learned that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

BHBK

Blue Hills Bancorp

$23.50

0.35 (1.51%)

16:10
09/20/18
09/20
16:10
09/20/18
16:10
Hot Stocks
Breaking Hot Stocks news story on Blue Hills Bancorp »

Blue Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$18.98

0.49 (2.65%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Karyopharm announces oral presentation relating to selinexor »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Earnings
Steelcase sees Q3 EPS 28c-33c, consensus 25c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

UNFI

United Natural Foods

$33.89

0.6 (1.80%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
United Natural Foods reports Q4 gross margin 14.5% down 125 bps y/y »

Gross margin for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

OPNT

Opiant Pharmaceuticals

$22.41

0.36 (1.63%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Opiant Pharmaceuticals enters into $4.6M contract with BARDA for OPTN003 »

Opiant Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UNFI

United Natural Foods

$33.92

0.63 (1.89%)

16:08
09/20/18
09/20
16:08
09/20/18
16:08
Hot Stocks
United Natural Foods sees FY19 effective tax rate 27.4%-28.4% »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

SCS

Steelcase

$16.05

0.75 (4.90%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Earnings
Steelcase reports Q2 EPS 41c, consensus 29c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

EDR

EdR

$41.49

(0.00%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Hot Stocks
EdR acquired by Greystar Real Estate for $4.6B »

EdR's acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.87

0.58 (1.74%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Earnings
United Natural Foods sees FY19 adjusted EPS $3.48-$3.58, consensus $3.54 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

MU

Micron

$45.97

0.92 (2.04%)

16:07
09/20/18
09/20
16:07
09/20/18
16:07
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron notes Q4 cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

ADBE

Adobe

$266.64

1.73 (0.65%)

16:06
09/20/18
09/20
16:06
09/20/18
16:06
Hot Stocks
Adobe to acquire Marketo for $4.75B »

Adobe announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

16:05
09/20/18
09/20
16:05
09/20/18
16:05
Earnings
United Natural Foods reports Q4 adjusted EPS 76c, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

ASM

Avino Silver & Gold Mines

$0.81

-0.0486 (-5.65%)

16:05
09/20/18
09/20
16:05
09/20/18
16:05
Syndicate
Avino Silver & Gold Mines files to sell common stock and warrants »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

MU

Micron

$45.98

0.93 (2.06%)

16:04
09/20/18
09/20
16:04
09/20/18
16:04
Hot Stocks
Micron notes secular, diversified growth drivers to drive results »

"Micron delivered an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

MU

Micron

$46.08

1.03 (2.29%)

16:03
09/20/18
09/20
16:03
09/20/18
16:03
Earnings
Micron reports Q4 EPS $3.53, consensus $3.34 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

TXN

Texas Instruments

$108.49

1.13 (1.05%)

16:02
09/20/18
09/20
16:02
09/20/18
16:02
Hot Stocks
Texas Instruments raises dividend 24%, announces $12B share repurchase plan »

Texas Instruments said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$108.48

1.12 (1.04%)

16:01
09/20/18
09/20
16:01
09/20/18
16:01
Hot Stocks
Breaking Hot Stocks news story on Texas Instruments »

Texas Instruments raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.